Proteomic Analysis in a Phase 2 Clinical Trial Studying CT1812 to Identify CSF and Plasma Pharmacodynamic Biomarkers and Molecular Correlates of EEG in Alzheimer&#39;s Disease Patients

Elayta (CT1812) - Cognition Therap

https://www.ctad-alzheimer.com/files/files/CTAD%20ABSTRACT%202023%20oct%2024_compressed.pdf

Valentina Di Caro 1; Kiran Pandey 2; Britney Lizama 1; Eunah Cho 1; Duc Duong 3, 4; Willem De Haan 5, 6; Michael Grundman 7; Nicholas Seyfried 4; Anthony Caggiano 1; Everard Vijverberg 6; Mary Hamby1

Oct 23, 2023